X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with Aurobindo Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs AUROBINDO PHARMA - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD AUROBINDO PHARMA ALEMBIC LTD/
AUROBINDO PHARMA
 
P/E (TTM) x 76.0 18.1 421.0% View Chart
P/BV x 2.8 5.9 48.1% View Chart
Dividend Yield % 0.4 0.4 112.5%  

Financials

 ALEMBIC LTD   AUROBINDO PHARMA
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
AUROBINDO PHARMA
Mar-16
ALEMBIC LTD/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs531,541 3.4%   
Low Rs29582 5.0%   
Sales per share (Unadj.) Rs4.7237.5 2.0%  
Earnings per share (Unadj.) Rs8.833.9 25.9%  
Cash flow per share (Unadj.) Rs9.040.6 22.2%  
Dividends per share (Unadj.) Rs0.152.50 6.0%  
Dividend yield (eoy) %0.40.2 155.1%  
Book value per share (Unadj.) Rs27.7120.6 23.0%  
Shares outstanding (eoy) m267.03585.17 45.6%   
Bonus/Rights/Conversions -PREF-  
Price / Sales ratio x8.74.5 194.6%   
Avg P/E ratio x4.731.3 14.9%  
P/CF ratio (eoy) x4.626.2 17.4%  
Price / Book Value ratio x1.58.8 16.8%  
Dividend payout %1.77.4 23.2%   
Avg Mkt Cap Rs m10,962621,041 1.8%   
No. of employees `000NA13.3 0.0%   
Total wages/salary Rs m23815,508 1.5%   
Avg. sales/employee Rs ThNM10,457.6-  
Avg. wages/employee Rs ThNM1,167.1-  
Avg. net profit/employee Rs ThNM1,491.6-  
INCOME DATA
Net Sales Rs m1,260138,961 0.9%  
Other income Rs m2641,663 15.9%   
Total revenues Rs m1,524140,624 1.1%   
Gross profit Rs m8332,056 0.3%  
Depreciation Rs m613,926 1.6%   
Interest Rs m02,568 0.0%   
Profit before tax Rs m28527,225 1.0%   
Minority Interest Rs m039 0.0%   
Prior Period Items Rs m2,0960-   
Extraordinary Inc (Exp) Rs m-320-   
Tax Rs m67,444 0.1%   
Profit after tax Rs m2,34319,820 11.8%  
Gross profit margin %6.623.1 28.5%  
Effective tax rate %2.127.3 7.8%   
Net profit margin %185.914.3 1,303.3%  
BALANCE SHEET DATA
Current assets Rs m1,689100,015 1.7%   
Current liabilities Rs m48674,759 0.7%   
Net working cap to sales %95.418.2 525.0%  
Current ratio x3.51.3 259.6%  
Inventory Days Days217107 202.0%  
Debtors Days Days81110 73.9%  
Net fixed assets Rs m1,62452,350 3.1%   
Share capital Rs m534585 91.3%   
"Free" reserves Rs m5,96067,707 8.8%   
Net worth Rs m7,40470,567 10.5%   
Long term debt Rs m1048,472 1.2%   
Total assets Rs m8,010156,994 5.1%  
Interest coverage x950.711.6 8,193.2%   
Debt to equity ratio x00.1 11.7%  
Sales to assets ratio x0.20.9 17.8%   
Return on assets %29.314.3 205.1%  
Return on equity %31.628.1 112.7%  
Return on capital %31.337.7 82.9%  
Exports to sales %2.951.0 5.8%   
Imports to sales %28.918.8 153.1%   
Exports (fob) Rs m3770,927 0.1%   
Imports (cif) Rs m36426,193 1.4%   
Fx inflow Rs m3771,015 0.1%   
Fx outflow Rs m36528,799 1.3%   
Net fx Rs m-32842,216 -0.8%   
CASH FLOW
From Operations Rs m34617,596 2.0%  
From Investments Rs m-48-13,801 0.3%  
From Financial Activity Rs m-301-198 151.8%  
Net Cashflow Rs m-33,597 -0.1%  

Share Holding

Indian Promoters % 64.0 54.1 118.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 8.0 2.5%  
FIIs % 9.7 27.7 35.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 10.2 255.9%  
Shareholders   54,701 69,601 78.6%  
Pledged promoter(s) holding % 0.0 8.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   CIPLA  PFIZER  NATCO PHARMA  SHASUN PHARMA  PIRAMAL ENTERPRISES  

Compare ALEMBIC LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Marginally Lower; IT Stocks Witness Losses(11:30 am)

Share markets in India are presently trading marginally lower. Sectoral indices are trading on a mixed note with stocks in the IT sector and power sector witnessing maximum selling pressure.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Aug 21, 2017 12:04 PM

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD - LUPIN LTD COMPARISON

COMPARE ALEMBIC LTD WITH

MARKET STATS